Synaptic basal lamina-associated congenital myasthenic syndromes
MYASTHENIA GRAVIS AND RELATED DISORDERS II
Authors: Maselli, Ricardo A.; Arredondo, Juan; Ferns, Michael J.; Wollmann, Robert L.
Abstract
Proteins associated with the basal lamina (BL) participate in complex signal transduction processes that are essential for the development and maintenance of the neuromuscular junction (NMJ). Most important junctional BL proteins are collagens, such as collagen IV(alpha 3-6), collagenXIII, andColQ; laminins; nidogens; and heparan sulfate proteoglycans, such as perlecan and agrin. Mice lacking Colq (Colq(-/-)), laminin beta 2 (Lamb2(-/-)), or collagen XIII (Col13a1(-/-)) show immature nerve terminals enwrapped by Schwann cell projections that invaginate into the synaptic cleft and decrease contact surface for neurotransmission. Human mutations in COLQ, LAMB2, and AGRN cause congenital myasthenic syndromes (CMSs) owing to deficiency of ColQ, laminin-beta 2, and agrin, respectively. In these syndromes the NMJ ultrastructure shows striking resemblance to that of mice lacking the corresponding protein; furthermore, the extracellular localization of mutant proteins may provide favorable conditions for replacement strategies based on gene therapy and stem cells.
Neurodevelopmental deficits in Pierson (microcoria-congenital nephrosis) syndrome
AMERICAN JOURNAL OF MEDICAL GENETICS PART A
Authors: Wuehl, Elke; Kogan, Jillene; Zurowska, Aleksandra; Matejas, Verena; Vandevoorde, Rene G.; Aigner, Thomas; Wendler, Olaf; Lesniewska, Iga; Bouvier, Raymonde; Reis, Andre; Weis, Joachim; Cochat, Pierre; Zenker, Martin
Abstract
Pierson syndrome is an autosomal recessive disorder comprising congenital nephrotic syndrome with diffuse mesangial sclerosis and distinct eye abnormalities with microcoria reported as the most prominent clinical feature. LAMB2 mutations leading to lack of laminin beta 2 were identified as the molecular cause underlying Pierson syndrome. Although LAMB2 is known to be expressed in the neuromuscular system, and defects of the neuromuscular junctions had been found in laminin beta 2-deficient mice, no consistent neurological phenotype has been described clinically in murine or human laminin beta 2-deficiency before. This is likely clue to the early lethality from renal failure. Here we provide a detailed description of neurological manifestations and development in four patients affected by Pierson syndrome, who survived until the age of 1.3-4.8 years owing to renal replacement therapy. Severe muscular hypotonia, psychomotor retardation, and blindness were present in three patients harboring truncating mutations on both LAMB2 alleles. These symptoms were not attributable to complications of chronic renal failure, thus representing a primary feature of the genetic disorder. Alterations in skeletal muscle tissue from one case were compatible with a chronic denervating process. one affected girl, however, exhibited a milder course of renal disease, normal development, and preserved vision, presumably owing to some residual LAMB2 function. Our findings indicate that severe neurodevelopmental deficits have to be considered as part of Pierson syndrome, at least in the presence of biallelic functional null mutations (complete lack of laminin beta 2). This is an important issue in the counseling of parents of an affected newborn or infant. (c) 2007 Wiley-Liss, Inc.